WYNZORA

Peak

calcipotriene and betamethasone dipropionate

NDATOPICALCREAM
Approved
Jul 2020
Lifecycle
Peak
Competitive Pressure
0/100

Mechanism of Action

Pharmacologic Class:

Vitamin D Analog

Loss of Exclusivity

LOE Date
Mar 18, 2039
158 months away
Patent Expiry
Mar 18, 2039

Patent Records (3)

Patent #ExpiryTypeUse Code
10265265
Sep 27, 2027
Product
—
11696919
Mar 18, 2039
Product
—
12440499
Mar 18, 2039
Product
U-1408
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers